Skip to main navigation Skip to search Skip to main content

Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis

Sara Comdühr*, Alexander Dübbers, Lars Tharun, Hanna Graßhoff, John Stone, Silke Pitann, Gabriela Riemekasten, Peter Lamprecht

*Corresponding author for this work
Original languageEnglish
JournalRheumatology (United Kingdom)
Volume61
Issue number11
Pages (from-to)E334-E336
ISSN1462-0324
DOIs
Publication statusPublished - 01.11.2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this